Supplement encyclopedia

OMEGA-3 FATTY ACIDS

Omega-3 is a family of polyunsaturated fatty acids. It includes alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Double-check the conclusions and read the sources before choosing a supplement.

Main conclusion

What it may offer

  • For dry eyes, pooling studies found that different EPA and DHA products reduced symptoms on average. In a separate large trial in adults with moderate or severe dry eyes, fish oil providing 2 g of EPA and 1 g of DHA a day showed no convincing advantage over olive oil over one year.
  • The EPA and DHA products studied may reduce muscle soreness 24–72 hours after exercise that lengthens the working muscle and help restore strength after muscle-damaging exercise.
  • In adults with osteoarthritis, the omega-3 products studied may slightly reduce pain and improve ratings of everyday physical function.
  • In girls and women aged 13–33, long-chain omega-3s may reduce menstrual pain; studies used 300–1800 mg a day for two or three months.
  • In a review of studies in adults with migraine, headache occurred on an average of 2.39 fewer days per month with omega-3 supplements or dietary changes.
  • In two separate trials in healthy adults, krill oil at 1 or 2 g a day reduced measured water loss through the skin over 12 weeks.
  • Studies in healthy adults without obesity found no convincing average increase in muscle strength from the omega-3 products studied.
  • In adults with overweight who were restricting calories, EPA and DHA gave no convincing additional reduction in weight or fat mass or preservation of the fat-free portion of body weight.

[1] [2] [3] [4] [5] [6] [7] [8] [9]

What was studied

  • A review of studies in adults aged 40 and over without dementia found no convincing improvement in overall thinking test scores. In the VITAL-Cog substudy, fish oil providing 460 mg of EPA and 380 mg of DHA a day also showed no convincing advantage in older participants.
  • A review of studies in adults with rheumatoid arthritis found no convincing average reduction in pain with the omega-3 products studied.

[1] [2] [3]

Which forms were considered

  • Omega-3 includes different fatty acids: ALA, EPA and DHA. Check the packaging to see which are in the product.
  • Fish oil contains EPA and DHA in varying amounts. Compare their amounts per serving: the total weight of oil includes other fatty acids too.
  • Microalgal oil usually contains DHA, and some products also contain EPA. Cod liver oil may contain vitamins A and D, so check the composition on the label.

[1]

How to get it from food

  • Flaxseed oil, chia seeds and walnuts provide ALA. The body converts it to EPA and DHA only to a limited extent.
  • Oily fish, such as salmon, herring and sardines, contain EPA and DHA. Their amounts depend on the fish species and portion.
  • Some eggs, dairy drinks and plant-based drinks are fortified with omega-3s. The composition and amounts of added fatty acids can be checked on the packaging.

[1]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Dry eye symptomsPooling studies found that dry eye symptoms decreased on average with the products studied; study results varied greatly.Standardised mean difference −1.02, 95% CI −1.51 to −0.53; I² 97%
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.
11 systematic review; 16 trials for this outcomeThe effects of different forms of omega-3 polyunsaturated fatty acids on dry eye disease resulting from various etiologies: a meta-analysis and systematic review. ↗Adults with dry eyes of various causes, including meibomian gland dysfunction, contact lens use, after surgery, rosacea or Sjögren's syndrome.
  1. The effects of different forms of omega-3 polyunsaturated fatty acids on dry eye disease resulting from various etiologies: a meta-analysis and systematic review. ↗
Overall thinking test scoreNo convincing average improvement in the overall thinking test score was found.Standardised mean difference 0.041, 95% CI −0.108 to 0.190
2/4 LowSome studies were small, with a risk of bias and incomplete reporting. Interventions and outcomes varied; study results could conflict. The assessment is limited to the stated group and measured outcome. The pooled result and confidence interval are provided. Publication bias cannot be ruled out.
11 systematic review; 24 trials in the whole reviewThe influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. ↗Adults aged 40 and over without dementia, including people with mild cognitive impairment.
  1. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. ↗
Muscle strengthNo convincing average increase in muscle strength was found.Standardised mean difference −0.02, 95% CI −0.38 to 0.34; very low certainty
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.
11 systematic review; 8 trials for this outcomeOmega-3 supplementation shows no clear benefit for fat-free mass or muscle strength in healthy adults: a systematic review and meta-analysis of randomized controlled trials. ↗Healthy adults without obesity; eight studies and 22 interrelated strength measures.
  1. Omega-3 supplementation shows no clear benefit for fat-free mass or muscle strength in healthy adults: a systematic review and meta-analysis of randomized controlled trials. ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake referencesUS adequate intake values for adults refer to ALA from the total diet: 1.6 g/day for men and 1.1 g/day for women; during pregnancy 1.4 g/day and breastfeeding 1.3 g/day. These are not EPA+DHA intake values.
Intake and studied regimensThe US Institute of Medicine has not established a tolerable upper intake level, UL, for omega-3s; this does not mean any dose is safe.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Forms

Omega-3 is a family of fatty acids. ALA is found mainly in plant sources; EPA and DHA in fish, fish and krill oils, and some algal products. Conversion of ALA to EPA and especially DHA is limited. Microalgal oil usually contains DHA; some products also contain EPA. Check the label of the specific product for its composition and the amount of each fatty acid. Fish oil contains EPA and DHA in varying amounts. The weight of oil is not the weight of EPA+DHA. Cod liver oil may also contain vitamins A and D.

Guidance for each goal

Dry eye symptoms1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

Pooling studies found that dry eye symptoms decreased on average with the products studied; study results varied greatly.

Study findings. Pooling studies found that dry eye symptoms decreased on average with the products studied; study results varied greatly.

Studied regimenDifferent doses and regimens were used across studies.Oral long-chain omega-3s: different EPA/DHA products, including krill oil.
Duration and populationStudy durations varied.Adults with dry eyes of various causes, including meibomian gland dysfunction, contact lens use, after surgery, rosacea or Sjögren's syndrome.

Pooling studies found that dry eye symptoms decreased on average with the products studied; study results varied greatly. Comparison: Control products varied between studies.

Overall thinking test score2/4 LowRead moreCollapse
Confidence
2/4 LowSome studies were small, with a risk of bias and incomplete reporting. Interventions and outcomes varied; study results could conflict. The assessment is limited to the stated group and measured outcome. The pooled result and confidence interval are provided. Publication bias cannot be ruled out.

No convincing average improvement in the overall thinking test score was found.

Study findings. No convincing average improvement in the overall thinking test score was found.

Studied regimenDoses and formulations varied.Different omega-3 products, including specific combinations.
Duration and populationFrom 3 to 36 months.Adults aged 40 and over without dementia, including people with mild cognitive impairment.

No convincing average improvement in the overall thinking test score was found. Comparison: Study control groups.

Muscle strength1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

No convincing average increase in muscle strength was found.

Study findings. No convincing average increase in muscle strength was found.

Studied regimenDoses varied.Different omega-3 products.
Duration and populationStudy durations varied.Healthy adults without obesity; eight studies and 22 interrelated strength measures.

No convincing average increase in muscle strength was found. Comparison: Study control groups.

Muscle soreness after exercise2/4 LowRead moreCollapse
Confidence
2/4 LowSome studies were small, with a risk of bias and incomplete reporting. Interventions and outcomes varied; study results could conflict. The assessment is limited to the stated group and measured outcome. The pooled result and confidence interval are provided. Publication bias cannot be ruled out.

The EPA and DHA products studied reduced peak muscle soreness after unfamiliar exercise that lengthens the working muscle.

Study findings. The EPA and DHA products studied reduced peak muscle soreness after unfamiliar exercise that lengthens the working muscle.

Studied regimenDoses and regimens varied.Products containing EPA and DHA.
Duration and populationPeak soreness 24–72 hours after exercise.Participants in nine placebo-controlled studies of exercise that lengthens the working muscle.

The EPA and DHA products studied reduced peak muscle soreness after unfamiliar exercise that lengthens the working muscle. Comparison: Placebo.

Pain in rheumatoid arthritis1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

No convincing average reduction in pain was found.

Study findings. No convincing average reduction in pain was found.

Studied regimenDoses varied.Omega-3 products.
Duration and populationStudy durations varied.Adults with rheumatoid arthritis; the review included 23 placebo-controlled studies.

No convincing average reduction in pain was found. Comparison: Placebo.

Water loss through the skin1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

In both trials, measured water loss through the skin decreased more with krill oil.

Study findings. In both trials, measured water loss through the skin decreased more with krill oil.

Studied regimen1 g of oil a day in one study and 2 g in the other.Krill oil.
Duration and population12 weeks.Healthy adults in two separate small trials.

In both trials, measured water loss through the skin decreased more with krill oil. Comparison: Placebo.

Headache days in migraine1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

On average, headache occurred on 2.39 fewer days per month than in the control groups.

Study findings. On average, headache occurred on 2.39 fewer days per month than in the control groups.

Studied regimenDoses and methods of use varied.Omega-3 supplements or changes to the whole diet.
Duration and populationStudy durations varied.Adults with migraine: seven studies with 652 participants.

On average, headache occurred on 2.39 fewer days per month than in the control groups. Comparison: Study control groups.

Menstrual pain1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowStudies were small or had methodological shortcomings; missing data and selective reporting are possible. Results varied greatly or were heterogeneous. Different products, administration methods, participant groups or indirect measures were used. A confidence interval is provided, but the precision of the pooled estimate remains uncertain. The influence of publication bias could not be assessed.

In the review, menstrual pain decreased on average with the products studied.

Study findings. In the review, menstrual pain decreased on average with the products studied.

Studied regimen300–1800 mg of long-chain omega-3s a day.Oral long-chain omega-3s; formulations varied.
Duration and populationTwo or three months.Girls and women aged 13–33 with menstrual pain.

In the review, menstrual pain decreased on average with the products studied. Comparison: Control groups of the individual studies.

Weight and body composition during calorie restriction2/4 LowRead moreCollapse
Confidence
2/4 LowSome studies were small, with a risk of bias and incomplete reporting. Interventions and outcomes varied; study results could conflict. The assessment is limited to the stated group and measured outcome. The pooled result and confidence interval are provided. Publication bias cannot be ruled out.

No convincing additional reduction in weight or fat mass or preservation of fat-free mass was found.

Study findings. No convincing additional reduction in weight or fat mass or preservation of fat-free mass was found.

Studied regimenProduct doses varied.Different EPA and DHA products.
Duration and population8–12 weeks.Adults with overweight; the review included 11 studies with 637 participants.

No convincing additional reduction in weight or fat mass or preservation of fat-free mass was found. Comparison: The same calorie restriction without omega-3s or with placebo.

Thinking in older VITAL-Cog participants2/4 LowRead moreCollapse
Confidence
2/4 LowNot all participants completed repeat tests; missing data and selection of substudy participants may have affected the result. Cognitive results came from two substudies with different testing methods and follow-up durations. The assessment is limited to the stated group and measured outcome. A confidence interval is provided for the difference in annual change in the overall test score. Publication bias cannot be ruled out.

No convincing improvement in the overall thinking test score was found.

Study findings. No convincing improvement in the overall thinking test score was found.

Studied regimen460 mg of EPA and 380 mg of DHA a day.Fish oil: 1 g of oil a day.
Duration and populationAn average of 2.8 years in the telephone group and 2 years in the in-person group.Older VITAL-Cog substudy participants: 3424 in the telephone group and 794 in the in-person group.

No convincing improvement in the overall thinking test score was found. Comparison: Placebo.

Dry eye symptoms: DREAM trial3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateNo additional substantial reasons to doubt the reliability of the result were identified for this comparison. There are no grounds for a separate downgrade. The study tested the specific form, participant group and outcome stated. The interval still allows a small effect. There are no specific data for a separate downgrade.

No convincing relief of symptoms compared with the control oil was found.

Study findings. No convincing relief of symptoms compared with the control oil was found.

Studied regimen2000 mg of EPA and 1000 mg of DHA a day; each capsule also contained 3 mg of vitamin E.Fish concentrate in triglyceride form, five soft capsules a day.
Duration and population12 months; the primary outcome compared baseline with the average of measurements at months six and twelve.Adults aged 18 and over with moderate or severe dry eye disease for at least six months; concomitant care was allowed.

No convincing relief of symptoms compared with the control oil was found. Comparison: Five capsules of refined olive oil, a total of 5 g a day; each contained 3 mg of vitamin E.

Strength recovery after exercise1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowSmall trials and different assessment methods. There are no grounds for a separate downgrade. Different products and protocols. The interval covers effects from small to noticeable. There are no specific data for a separate downgrade.

The EPA and DHA products studied may help restore strength after exercise that causes substantial muscle damage.

Study findings. The EPA and DHA products studied may help restore strength after exercise that causes substantial muscle damage.

Studied regimenDoses and regimens varied.Different long-chain omega-3 products containing EPA and DHA.
Duration and populationThe period of greatest strength impairment after muscle-damaging exercise.Healthy young and middle-aged adults in placebo-controlled studies of exercise that lengthens the working muscle.

The EPA and DHA products studied may help restore strength after exercise that causes substantial muscle damage. Comparison: Placebo.

Pain in osteoarthritis1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowHeterogeneous methods across individual trials. Differences in results and protocols. Products and clinical situations vary. There are enough data for a limited conclusion. There are no specific data for a separate downgrade.

The omega-3 products studied may slightly reduce pain.

Study findings. The omega-3 products studied may slightly reduce pain.

Studied regimenDoses varied.Different omega-3 products.
Duration and populationStudy durations varied.Adults with osteoarthritis in the relevant trials.

The omega-3 products studied may slightly reduce pain. Comparison: Control groups of the individual trials.

Everyday physical function in osteoarthritis2/4 LowRead moreCollapse
Confidence
2/4 LowHeterogeneous methods across individual trials. There are no grounds for a separate downgrade. Products and clinical situations vary. There are enough data for a limited conclusion. There are no specific data for a separate downgrade.

The omega-3 products studied slightly improved the rating of everyday physical function.

Study findings. The omega-3 products studied slightly improved the rating of everyday physical function.

Studied regimenDoses varied.Different omega-3 products.
Duration and populationStudy durations varied.Adults with osteoarthritis in the relevant trials.

The omega-3 products studied slightly improved the rating of everyday physical function. Comparison: Control groups of the individual trials.

Safety and limitations

Fish oil supplements may cause an unpleasant taste, belching, heartburn, nausea or diarrhoea. A review of 35 studies with 114 592 participants separately compared studies in people at high cardiovascular risk receiving more than 1.5 g of EPA+DHA a day. In this group of studies, atrial fibrillation was more frequent: odds ratio OR 1.43 (95% CI 1.14–1.79), absolute difference +0.8 percentage points. The review included trials in adults aged 50 and over taking EPA/DHA for at least a year. The dose threshold was used to divide studies into groups; it does not define an individual's safe dose. A review of 11 trials found no convincing difference in overall bleeding frequency: RR 1.09 (95% CI 0.91–1.31). For high-dose purified EPA, a separate prescription intervention, an increase was noted: RR 1.50 (95% CI 1.13–1.99), absolute difference about +0.6 percentage points. This subgroup result concerns the product and regimen studied. In a review, additional long-chain omega-3 intake during pregnancy was associated with a higher frequency of pregnancy lasting beyond 42 weeks: 2.6% versus 1.6%, RR 1.61 (95% CI 1.11–2.33). This is gestational duration, not the duration of supplement use. Studies used different supplements, dietary interventions and intake periods.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗ · Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals ↗ · Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials ↗ · Omega-3 fatty acid addition during pregnancy ↗

Interactions

WithEffectActionSource
Warfarin and fish oil supplements (marine EPA/DHA)Fish oil may alter INR when taking warfarin. In a small RCT with 16 enrolled participants, five of whom dropped out, no clear difference in INR versus placebo was found over four weeks; the result concerns the products and conditions studied.When starting, stopping or changing the dose of fish oil, tell the specialist managing warfarin the product's composition and dose and agree on INR monitoring; do not change the warfarin dose yourself.Omega-3 Fatty Acids - Health Professional Fact Sheet ↗
Effects of Marine Fish Oils on the Anticoagulation Status of Patients Receiving Chronic Warfarin Therapy ↗

Food sources

Fish and seafood rows show the sum of EPA and DHA without DPA or other fatty acids; plant oil, seed and black walnut rows show ALA. ALA amounts cannot be equated with EPA+DHA or research effects transferred between them. Portions are selected comparison weights of the edible part in the stated condition, 85 g for fish and seafood. USDA SR28 data refer to 2015. Some fish values are calculated: code RA means recipe calculation with approximate ingredient proportions, rather than direct analysis of a prepared sample. Some eggs, yoghurts, milk and plant-based drinks are fortified with omega-3s: check the current label composition.

Salmon and trout

Farmed, cooked Atlantic salmon: in 3 ounces (about 85 g), DHA 1240 mg and EPA 590 mg; wild cooked Atlantic salmon: DHA 1220 mg and EPA 350 mg; wild cooked rainbow trout: DHA 440 mg and EPA 400 mg in the same portion.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Herring, sardines and mackerel

Cooked Atlantic herring, 3 ounces (about 85 g): DHA 940 mg and EPA 770 mg; sardines canned in tomato sauce, drained: DHA 740 mg and EPA 450 mg; cooked Atlantic mackerel: DHA 590 mg and EPA 430 mg in the same portion.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Other fish and canned products

Cooked sea bass, 3 ounces (about 85 g): DHA 470 mg and EPA 180 mg; canned light tuna in water, drained: DHA 170 mg and EPA 20 mg; cooked Pacific cod: DHA 100 mg and EPA 40 mg in the same portion.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Molluscs and crustaceans

Cooked wild Eastern oysters, 3 ounces (about 85 g): DHA 230 mg and EPA 300 mg; cooked shrimp: DHA 120 mg and EPA 120 mg; cooked scallops: DHA 90 mg and EPA 60 mg in the same portion.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Plant sources of ALA

Flaxseed oil, 1 tablespoon: 7260 mg of ALA; chia seeds, 1 ounce (about 28 g): 5060 mg of ALA; walnuts, 1 ounce (about 28 g): 2570 mg of ALA. This is ALA, not preformed EPA and DHA; it cannot be converted into an equal amount of EPA+DHA.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Fortified foods and eggs

Some eggs, yoghurts, milk and plant-based drinks are additionally fortified with DHA or other omega-3s; check the label for composition and amounts. In the NIH table, one cooked egg contains 30 mg of DHA.

Omega-3 Fatty Acids - Health Professional Fact Sheet ↗

Food composition

FoodGroupAmountServingCaloriesSources
Atlantic salmon, farmedfarmed, cooked with dry heatSalmon and trout2.147 g of EPA+DHA / 100 g85 g · 1.82495 g of EPA+DHA · 175.1 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.206 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Atlantic salmon, wildwild, cooked with dry heatSalmon and trout1.84 g of EPA+DHA / 100 g85 g · 1.564 g of EPA+DHA · 154.7 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.182 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Sockeye salmoncooked with dry heatSalmon and trout0.859 g of EPA+DHA / 100 g85 g · 0.73015 g of EPA+DHA · 132.6 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.156 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
USDA Food and Nutrient Database for Dietary Studies 2015–2016: Documentation (2018) ↗
Rainbow trout, farmedfarmed, cooked with dry heatSalmon and trout0.875 g of EPA+DHA / 100 g85 g · 0.74375 g of EPA+DHA · 142.8 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.168 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
USDA Food and Nutrient Database for Dietary Studies 2015–2016: Documentation (2018) ↗
Rainbow trout, wildwild, cooked with dry heatSalmon and trout0.988 g of EPA+DHA / 100 g85 g · 0.8398 g of EPA+DHA · 127.5 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.150 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Atlantic herringcooked with dry heatOily fish2.014 g of EPA+DHA / 100 g85 g · 1.7119 g of EPA+DHA · 172.55 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.203 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Atlantic mackerelcooked with dry heatOily fish1.203 g of EPA+DHA / 100 g85 g · 1.02255 g of EPA+DHA · 222.7 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.262 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Atlantic sardinesin oil, drained solids, with bonesCanned fish0.982 g of EPA+DHA / 100 g85 g · 0.8347 g of EPA+DHA · 176.8 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.208 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Canned sockeye salmonwithout salt, drained solids, with bonesCanned fish1.156 g of EPA+DHA / 100 g85 g · 0.9826 g of EPA+DHA · 130.05 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.153 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Light tuna in waterin water, drained solidsCanned fish0.224 g of EPA+DHA / 100 g85 g · 0.1904 g of EPA+DHA · 73.1 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.86 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Light tuna in oilin oil, without salt, drained solidsCanned fish0.128 g of EPA+DHA / 100 g85 g · 0.1088 g of EPA+DHA · 168.3 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.198 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Pacific codcooked with dry heat, may have been previously frozenOther fish0.16 g of EPA+DHA / 100 g85 g · 0.136 g of EPA+DHA · 72.25 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.85 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
USDA Food and Nutrient Database for Dietary Studies 2015–2016: Documentation (2018) ↗
Eastern oysterswild, cooked with moist heatMolluscs and crustaceans0.624 g of EPA+DHA / 100 g85 g · 0.5304 g of EPA+DHA · 86.7 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.102 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
Shrimpmixed species, cooked with moist heat, may have been previously frozenMolluscs and crustaceans0.276 g of EPA+DHA / 100 g85 g · 0.2346 g of EPA+DHA · 101.15 kcalSelected comparison weight: 85 g of edible portion in the stated condition; EPA+DHA total and calories calculated from values per 100 g in a single record. This is a comparison weight, not a USDA recommendation.119 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
USDA Food and Nutrient Database for Dietary Studies 2015–2016: Documentation (2018) ↗
Flaxseed oilcold-pressedVegetable oils53.368 g of ALA / 100 g13.6 g · 7.258048 g of ALA · 120.224 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.884 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 04 ↗
Rapeseed oilcanola oilVegetable oils9.137 g of ALA / 100 g14 g · 1.27918 g of ALA · 123.76 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.884 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 04 ↗
Soybean oiloil for salads or cookingVegetable oils6.789 g of ALA / 100 g13.6 g · 0.923304 g of ALA · 120.224 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.884 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 04 ↗
Chia seedsdried seedsSeeds and nuts17.83 g of ALA / 100 g28.35 g · 5.054805 g of ALA · 137.781 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.486 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗
Hemp seedshulled seedsSeeds and nuts8.684 g of ALA / 100 g30 g · 2.6052 g of ALA · 165.9 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.553 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗
Black walnutsdried black walnut kernelsSeeds and nuts2.677 g of ALA / 100 g28.35 g · 0.7589295 g of ALA · 175.4865 kcalSelected comparison weight of the edible portion in the stated condition; calculated from values per 100 g.619 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
The effects of different forms of omega-3 polyunsaturated fatty acids on dry eye disease resulting from various etiologies: a meta-analysis and systematic review. ↗Dry eye symptomsAdults with dry eyes of various causes, including meibomian gland dysfunction, contact lens use, after surgery, rosacea or Sjögren's syndrome.Oral long-chain omega-3s: different EPA/DHA products, including krill oil.; Different doses and regimens were used across studies.; Study durations varied.; comparison: Control products varied between studies.Dry eye symptoms: Pooling studies found that dry eye symptoms decreased on average with the products studied; study results varied greatly.
The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. ↗Overall thinking test scoreAdults aged 40 and over without dementia, including people with mild cognitive impairment.Different omega-3 products, including specific combinations.; Doses and formulations varied.; From 3 to 36 months.; comparison: Study control groups.Overall thinking test score: No convincing average improvement in the overall thinking test score was found.

Sources

Sources
  1. Omega-3 Fatty Acids - Health Professional Fact Sheet ↗
  2. Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals ↗
  3. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials ↗
  4. Omega-3 fatty acid addition during pregnancy ↗
  5. Effects of Marine Fish Oils on the Anticoagulation Status of Patients Receiving Chronic Warfarin Therapy ↗
  6. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 15 ↗
  7. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 04 ↗
  8. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 12 ↗
  9. USDA Food and Nutrient Database for Dietary Studies 2015–2016: Documentation (2018) ↗
  10. The effects of different forms of omega-3 polyunsaturated fatty acids on dry eye disease resulting from various etiologies: a meta-analysis and systematic review. ↗
  11. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. ↗
  12. Omega-3 supplementation shows no clear benefit for fat-free mass or muscle strength in healthy adults: a systematic review and meta-analysis of randomized controlled trials. ↗
  13. Effects of LC n-3 PUFA Supplementation on Muscle Pain, Function, and Damage Markers in Healthy Young to Middle-Aged Adults Following Acute or Chronic Exercise: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ↗
  14. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled trials. ↗
  15. Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis. ↗
  16. Effects of Long-Chain n-3 Fatty Acids Supplementation During Caloric Restriction on Body Composition in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ↗
  17. Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis. ↗
  18. Krill oil supplementation improves transepidermal water loss, hydration and elasticity of the skin in healthy adults: Results from two randomized, double-blind, placebo-controlled, dose-finding pilot studies. ↗
  19. Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial. ↗
  20. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. ↗
  21. Dosing effects of omega-3 fatty acid interventions in adults with migraine: Systematic review and meta-analysis of randomized clinical trials ↗